Metronidazole Intravenous Iv Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV)
Available Strengths: 500 mg/100 mL, 1 g/100 mL
Reference Brands: Flagyl(US), Metronidazol-Darnytsia (Ukraine)
Category:
Medical Aid
Metronidazole IV inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structures. It provides rapid, effective treatment for severe anaerobic infections, abscesses, and protozoal diseases. Benefits include quick bacterial eradication, good tissue penetration, and use in critical care when oral therapy isn’t feasible.
Metronidazole intravenous IV is available in Intravenous (IV)
and strengths such as 500 mg/100 mL, 1 g/100 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Metronidazole intravenous IV is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Metronidazole intravenous IV can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Metronidazole IV is approved in the EU and US for serious anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl IV are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy in severe infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing